Skip to main content

Advertisement

Table 2 The differences in clinicopathological parameters between patients with and without chronic lymphocytic thyroiditis (CLT)

From: The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer

Parameters Malignancy (+) CLT (-) Malignancy (+) CLT (+) Total P
  (n = 100) (n = 44) (n = 144)  
Tumor size (cm)     
  d ≤2 59 (59.0%) 34 (77.3%) 93 (64.6%) 0.073
  2 < d ≤4 28 (28.0%) 8 (18.2%) 36 (25.0%)
  d >4 13 (13.0%) 2 (4.5%) 15 (10.4%)
Multifocality     
  No 79 (79.0%) 36 (81.8%) 115 (79.9%) 0.0871
  Yes 21 (21.0%) 8 (22.2%) 29 (20.1%)  
Neck lymph node metastasis     
  No 65 (65.0%) 25 (56.8%) 90 (62.5%) 0.350
  Yes 35 (35.0%) 19 (43.2%) 54 (37.5%)  
Gender     
  Female 65 (65.0%) 41 (93.2%) 106 (73.6%) <0.001
  Male 35 (35.0%) 3 (6.8%) 38 (26.4%)  
Age     
  <45 years 41 (41.0%) 22 (50.0%) 63 (43.7%) 0.316
  ≥45 years 59 (59.0%) 22 (50.0%) 81 (56.3%)  
Microcarcinoma     
  No 68 (68.0%) 30 (68.2%) 98 (68.1%) 0.983
  Yes 32 (32.0%) 14 (31.8%) 46 (31.9%)  
TNM stage     
  I 57 (68.7%) 26 (31.3%) 83 (57.6%) 0.949
  II 23 (67.6%) 11 (32.4%) 34 (23.6%)  
  III 11 (73.3%) 4 (26.7%) 15 (10.4%)  
  IVA 9 (75.0%) 3 (25.0%) 12 (8.3%)  
  1. CLT, chronic lymphocytic thyroiditis; CLT (+), malignancy of patients with CLT; CLT (-), malignancy of patients without CLT; TNM stage, tumor-node-metastasis stage.